Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03505710
Title DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer (DESTINY-Lung01)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | FRA | ESP


No variant requirements are available.